Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 790 GBX -0.82% Market Closed
Market Cap: 1B GBX
Have any thoughts about
Indivior PLC?
Write Note

Indivior PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Indivior PLC
Operating Income Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Indivior PLC
LSE:INDV
Operating Income
$264m
CAGR 3-Years
9%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
GlaxoSmithKline PLC
LSE:GSK
Operating Income
ÂŁ7.6B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Operating Income
$10.3B
CAGR 3-Years
34%
CAGR 5-Years
19%
CAGR 10-Years
13%
Verona Pharma PLC
NASDAQ:VRNA
Operating Income
-$155.4m
CAGR 3-Years
-37%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Income
$617m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
3%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Income
ÂŁ24.9m
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
3%

See Also

What is Indivior PLC's Operating Income?
Operating Income
264m USD

Based on the financial report for Jun 30, 2024, Indivior PLC's Operating Income amounts to 264m USD.

What is Indivior PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-9%

Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Indivior PLC have been 9% over the past three years , -5% over the past five years , and -9% over the past ten years .

Back to Top